|
Video: What is a Stock Split?
|
|
Artivion is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. Co. has the following product families: aortic stents and stent grafts, surgical sealants, On-X® mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stents and stent grafts include JOTEC® stent grafts and surgical products, the Ascyrus Medical Dissection Stent hybrid prosthesis, and the NEXUS® endovascular stent graft system. Surgical sealants include BioGlue® Surgical Adhesive products. According to our CRY split history records, CRY has had 2 splits. | |
|
CRY (CRY) has 2 splits in our CRY split history database. The first split for CRY took place on July 01, 1996. This was a 2 for 1
split, meaning for each share of CRY owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. CRY's second split took place on December 28, 2000. This was a 3 for 2 split, meaning for each 2 shares of CRY owned pre-split, the shareholder now owned 3 shares. For example, a 2000 share position pre-split, became a 3000 share position following the split.
When a company such as CRY splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the CRY split history from start to finish, an original position size of 1000 shares would have turned into 3000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CRY shares, starting with a $10,000 purchase of CRY, presented on a split-history-adjusted basis factoring in the complete CRY split history.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
01/21/2022 |
|
Start price/share: |
$9.66 |
|
End price/share: |
$17.88 |
|
Starting shares: |
1,035.20 |
|
Ending shares: |
1,056.89 |
|
Dividends reinvested/share: |
$0.21 |
|
Total return: |
88.97% |
|
Average Annual Total Return: |
8.57% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$18,896.63 |
|
Years: |
7.74 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
01/21/2022 |
|
Start price/share: |
$9.66 |
|
End price/share: |
$17.88 |
|
Dividends collected/share: |
$0.21 |
|
Total return: |
87.27% |
|
Average Annual Total Return: |
8.44% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$18,722.21 |
|
Years: |
7.74 |
|
|
|
Date |
Ratio |
07/01/1996 | 2 for 1
| 12/28/2000 | 3 for 2 |
|
|